![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Fierce Biotech Layoff Tracker 2025
3 days ago · Jan. 29 - I-Mab: After announcing a pipeline restructure earlier in the month, I-Mab’s has reduced its workforce by around 27%. Story. Jan. 28 - Zentalis Pharmaceuticals: In hopes of extending ...
After 3 big exits, Lightstone snags largest fund yet with $375M …
Sep 14, 2021 · After seeing Ra Pharmaceuticals, Disarm Therapeutics and Tizona Therapeutics to exits last year, Lightstone Ventures is back with $375 million to plant a seed in early-stage biotech and medtech sta
Fierce Biotech Layoff Tracker 2024
Jan 2, 2025 · We really didn't want to have to create another Layoff Tracker this year. But here we are, launching the third annual iteration tracking industry layoffs. Last year, we tallied 187 total layoffs ...
Fierce Biotech Fundraising Tracker 2024
Jan 2, 2025 · A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...
Syncona merges Freeline, SwanBio into new gene therapy biotech
Jun 17, 2024 · Seven months after Syncona threw a financial lifeline to struggling Freeline Therapeutics, the London-based investment firm is giving the biotech another present in the form of fellow gene therapy ...
Fierce Biotech News & Reports
Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
Cour inks $940M-plus autoimmune deal with Roche's Genentech
Dec 3, 2024 · Founded in 2013, Cour is broadly looking to develop novel reverse vaccines that reprogram the body’s white blood cells to avoid attacking healthy organs. To start, the company is focusing on ...
Navigator raises $100M to develop new autoimmune pipeline
Aug 27, 2024 · Navigator Medicines has equipped itself with $100 million in series A funds as the young biotech charts a course for its newly acquired autoimmune drugs.. The company, which was founded earlier ...
BridgeBio’s offshoot GondolaBio launches with $300M - Fierce …
Aug 21, 2024 · The new Delaware-based company has received $300 million in tranched financing from an investor group that includes Viking Global Investors, Patient Square Capital, Sequoia Capital, Frazier Life ...
Micreos lands $37M to show whether antibiotic alternative …
Oct 1, 2021 · The fresh funding will support development of two lead compounds, XZ.700 and SP.800. XZ.700 is in phase 1/2 development in mild to moderate atopic dermatitis.